Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yu-Ma Yang
Observed name:
Y. Yang
Institutions:
Guangdong University of Petrochemical Technology,
University of Hong Kong
Observed institutions:
Guangdong University of Petrochemical Technology,
Sun Yat-sen University Cancer Center,
University of Hong Kong
ORCID:
0000-0001-5466-7941
Observed ORCID:
0000-0001-5466-7941
OpenAlex ID:
A5083498615
FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
·
Cancer Research
·
130
CXCR4-engineered fibroblast membrane nanovesicles for Photothermal-enhanced ferroptotic therapy through chemokine-navigated tumor homing
2025
·
Lu Bai
, Ya-Nan Tan
, et al.
·
Journal of Nanobiotechnology
·
4
Preparation of superhydrophobic MnO 2 nanorod-Fe 3 O 4 nanoparticle functionalized melamine sponges for oil–water separation
2025
·
Jian-Wu Xiao
, Li-Wang Jiang
, et al.
·
New Journal of Chemistry
·
2
Preparation of a novel electrospun superhydrophobic magnetic CoFe 2 O 4 @TiO 2 /PVDF composite film with catalytic function and enhanced polar crystal content in PVDF
2025
·
Jian-Wu Xiao
, Li-Wang Jiang
, et al.
·
New Journal of Chemistry
·
1
Figure S4 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S7 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S3 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Supplementary Tables from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S6 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Data from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S4 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S3 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S5 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S2 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S1 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S1 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S2 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
332P A phase II, open-label, single-center study of QL1706 plus platinum doublet chemotherapy with bevacizumab as first-line treatment in patients with advanced NSCLC: Data from EGFR mutant cohort
2022
·
W. Fang
, Y. Yang
, et al.
·
Annals of Oncology
325P A phase II, open-label, single-center study of QL1706 plus platinum doublet chemotherapy with or without bevacizumab as first-line treatment in patients with advanced NSCLC: Data from EGFR wild-type cohort
2022
·
Y. Huang
, W. Fang
, et al.
·
Annals of Oncology
Retinoic acid protects from experimental cerebral infarction by upregulating GAP-43 expression
2019
·
Y. Li
, X. Gao
, et al.
·
Figshare
Show more works
View as search
Works count:
20
Citation count:
137
H-index:
2
I10-index:
1
Year
Topic
Type